Maraviroc (Celsentri)

BNF:

not listed

Status:

Red

Decision Date:

April 2018

Comments

RED: use in combination with other antiretroviral medicinal products for the treatment-experienced adolescents and children.

NHS England commissioned - to be used in line with NHSE commissioning intentions.

Red Drug Classifications

• 1: Requiring specialist assessment to enable patient selection, initiation and ongoing treating

search again